Kelly D. Sullivan

4.3k total citations
49 papers, 2.5k citations indexed

About

Kelly D. Sullivan is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kelly D. Sullivan has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kelly D. Sullivan's work include Cancer-related Molecular Pathways (11 papers), Down syndrome and intellectual disability research (8 papers) and Epigenetics and DNA Methylation (8 papers). Kelly D. Sullivan is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Down syndrome and intellectual disability research (8 papers) and Epigenetics and DNA Methylation (8 papers). Kelly D. Sullivan collaborates with scholars based in United States, Italy and France. Kelly D. Sullivan's co-authors include Joaquı́n M. Espinosa, Matthew D. Galbraith, Zdeněk Andrysík, William F. Marzluff, Ahwan Pandey, Keith P. Smith, Eric J. Wagner, Anna L. Guarnieri, Amanda A. Hill and James DeGregori and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kelly D. Sullivan

48 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly D. Sullivan United States 26 1.6k 613 372 303 282 49 2.5k
Andrew J. Andrews United States 26 2.4k 1.5× 566 0.9× 354 1.0× 98 0.3× 209 0.7× 48 3.1k
Matthew D. Galbraith United States 22 1.8k 1.1× 759 1.2× 744 2.0× 175 0.6× 267 0.9× 48 2.7k
Fabrizio Condorelli Italy 23 1.4k 0.8× 508 0.8× 496 1.3× 116 0.4× 272 1.0× 58 2.6k
Karin Sundfeldt Sweden 30 1.3k 0.8× 521 0.8× 606 1.6× 306 1.0× 327 1.2× 91 2.7k
Marilène Paquet Canada 30 1.8k 1.1× 376 0.6× 371 1.0× 450 1.5× 404 1.4× 77 2.8k
Jaeyeon Kim United States 24 811 0.5× 326 0.5× 323 0.9× 322 1.1× 308 1.1× 54 2.0k
Shinichiro Takahashi Japan 26 1.5k 0.9× 403 0.7× 290 0.8× 120 0.4× 427 1.5× 112 2.6k
Zhenbo Zhang China 26 1.1k 0.7× 343 0.6× 361 1.0× 124 0.4× 443 1.6× 84 2.0k
Makoto Kubo Japan 30 1.3k 0.8× 918 1.5× 571 1.5× 167 0.6× 502 1.8× 126 3.0k

Countries citing papers authored by Kelly D. Sullivan

Since Specialization
Citations

This map shows the geographic impact of Kelly D. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly D. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly D. Sullivan more than expected).

Fields of papers citing papers by Kelly D. Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly D. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly D. Sullivan. The network helps show where Kelly D. Sullivan may publish in the future.

Co-authorship network of co-authors of Kelly D. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly D. Sullivan. A scholar is included among the top collaborators of Kelly D. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly D. Sullivan. Kelly D. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waugh, Katherine A., et al.. (2026). Altered hepatic metabolism in Down syndrome. Cell Reports. 45(1). 116835–116835.
2.
Donovan, Micah G., Paula Araya, Angela L. Rachubinski, et al.. (2025). An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. Nature Communications. 16(1). 8346–8346. 1 indexed citations
3.
Donovan, Micah G., Angela L. Rachubinski, Keith P. Smith, et al.. (2024). Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome. Cell Reports. 43(8). 114599–114599. 4 indexed citations
4.
Ludwig, Michael P., Matthew D. Galbraith, Amanda A. Hill, et al.. (2023). Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway. Cancer Research. 83(15). 2543–2556. 8 indexed citations
5.
Galbraith, Matthew D., Angela L. Rachubinski, Keith P. Smith, et al.. (2023). Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. Science Advances. 9(26). eadg6218–eadg6218. 26 indexed citations
6.
Espinosa, Joaquı́n M., Kelly D. Sullivan, Andrew Goodspeed, et al.. (2023). Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection. iScience. 26(8). 107361–107361. 2 indexed citations
7.
Jewett, Cayla E, Eileen O’Toole, Katherine S. Given, et al.. (2022). Trisomy 21 induces pericentrosomal crowding delaying primary ciliogenesis and mouse cerebellar development. eLife. 12. 9 indexed citations
8.
Galbraith, Matthew D., Kohl T. Kinning, Kelly D. Sullivan, et al.. (2021). Seroconversion stages COVID19 into distinct pathophysiological states. eLife. 10. 34 indexed citations
9.
Liggett, L. Alexander, Matthew D. Galbraith, Keith P. Smith, et al.. (2021). Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation. Blood Advances. 5(7). 1791–1796. 13 indexed citations
10.
Tuttle, Kathryn D., Katherine A. Waugh, Paula Araya, et al.. (2020). JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome. Cell Reports. 33(7). 108407–108407. 31 indexed citations
11.
Estrada, Belinda Enriquez, Kelly D. Sullivan, Ross E. Granrath, et al.. (2019). Characterization of circulating T cells in people with and without Down syndrome. OSF Preprints (OSF Preprints). 1 indexed citations
12.
Brubaker, Lindsay W., Zachary L. Watson, Lubna Qamar, et al.. (2019). Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination. iScience. 19. 474–491. 23 indexed citations
13.
Galati, Domenico F., et al.. (2018). Trisomy 21 Represses Cilia Formation and Function. Developmental Cell. 46(5). 641–650.e6. 36 indexed citations
14.
Andrysík, Zdeněk, Matthew D. Galbraith, Anna L. Guarnieri, et al.. (2017). Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity. Genome Research. 27(10). 1645–1657. 108 indexed citations
15.
Andrews, Forest H., Qiong Tong, Kelly D. Sullivan, et al.. (2016). Multivalent Chromatin Engagement and Inter-domain Crosstalk Regulate MORC3 ATPase. Cell Reports. 16(12). 3195–3207. 34 indexed citations
16.
Tentler, John J., Aik Choon Tan, Todd M. Pitts, et al.. (2015). p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14(5). 1117–1129. 39 indexed citations
17.
Sullivan, Kelly D., et al.. (2014). ATM regulates cell fate choice upon p53 activation by modulating mitochondrial turnover and ROS levels. Cell Cycle. 14(1). 56–63. 32 indexed citations
18.
Couts, Kasey L., et al.. (2012). Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions. Oncogene. 32(15). 1959–1970. 41 indexed citations
19.
Sullivan, Kelly D., et al.. (2012). The p53 circuit board. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1825(2). 229–244. 81 indexed citations
20.
Sullivan, Kelly D., et al.. (2009). A Core Complex of CPSF73, CPSF100, and Symplekin May Form Two Different Cleavage Factors for Processing of Poly(A) and Histone mRNAs. Molecular Cell. 34(3). 322–332. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026